The TGA has concluded several international agreements and agreements with other countries and regulatory authorities to support international regulatory cooperation. Some of these agreements and agreements allow us to use the inspections carried out by these regulators as part of the GMP release procedure instead of our own on-site inspection. Australia has a Mutual Recognition Agreement (MRA) with the European Community (EC) and the European Free Trade Association (EFTA). Manufacturers approved by the APVMA and wishing to export veterinary medicines to Europe must be checked by the TGA. This test must be requested by the APVMA and not by the manufacturer. The APVMA evaluates the results of the TGA tests and can then issue a GMP certificate to the manufacturer. Under the MRA, the EC recognises the TGA as the authority responsible for the inspection of veterinary premises in Australia. . . . Manufacturers and sponsors need to be aware of their responsibilities.
For more information, please see: Only Australian production sites can obtain a manufacturing license. From application to the end of the process (including on-site inspection) can take time: we do not accept any evidence from a PIC/S participating authority if: no batch (including validation lots) manufactured prior to the licence or certification can be sold or delivered to Australia or exported from Australia, unless prior authorization has been obtained. Manufacturers with both TGA and APVMA licenses may opt for APVMA to conduct routine inspections by the TGA. The licensee notifies the APVMA of this decision. The TGA will not inspect aspects of the production plant that are intended only for wildlife products. New Zealand Medicines and Medical Device Safety Authority (Medsafe) We have a cooperation agreement with the U.S. FDA. We accept U.S. FDA evidence regarding GMP marketing authorization applications using the CV pathway, regardless of inspection procedure, as long as the inspection has been conducted with a comparable GMP standard. This joint membership in PIC/S allows us, in certain circumstances, to provide evidence to these regulators through the release route of the GMP CV. You must also decide whether your products are subject to regulatory and GMP standards that vary in Australia. This is particularly likely: GMP certification applications must be submitted by the Australian sponsor or by an agent acting on behalf of the Australian sponsor.
The National Authority of Medicines and Health Products (Infarmed) GMP certification is generally only required if it is not possible to obtain the GMP license through the Mutual Recognition Agreement (MRA) or Compliance Pathways (CV) channels, for example. B due to lack of evidence.